Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gedeon Richter Polska, historically known as Polfa Grodzisk, is a major pharmaceutical manufacturer and a key subsidiary of the Hungarian Gedeon Richter Group. Located in Grodzisk Mazowiecki, Poland, the company specializes in the development, production, and marketing of high-quality medicinal products across several therapeutic areas, including virology, cardiology, and neurology. The facility is one of the most advanced pharmaceutical production sites in Poland, holding multiple GMP certifications and serving as a strategic hub for the Central and Eastern European markets. Its most prominent product is the antiviral medication Groprinosin, which has achieved significant market penetration. Since its acquisition in 2002, the company has integrated into Gedeon Richter's global supply chain, serving as a strategic hub for the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polfa Grodzisk.